How to Help Your Patients Find Fosfomycin In Stock: A Provider's Guide

Fosfomycin (Monurol; fosfomycin tromethamine) is an IDSA first-line antibiotic for uncomplicated UTIs — but patients regularly call back after discovering their pharmacy is out of stock. This adds burden to your clinical team, delays patient treatment, and creates unnecessary anxiety. This guide gives your practice a systematic approach to minimizing these disruptions.

Why Patients Can't Fill Fosfomycin: The Root Cause

Fosfomycin is a single-dose antibiotic. This unique characteristic — while clinically convenient — creates pharmacy stock dynamics that differ from multi-day regimens. Pharmacies earn revenue by filling complete courses. A fosfomycin prescription is a single packet; the revenue-per-fill is low and inventory turns over slowly. Small pharmacies may keep only 2-5 packets on hand. A few prescriptions in quick succession can exhaust their supply for days.

This is not a national shortage — it is an inventory management pattern. The medication is available; it just may not be at the patient's preferred pharmacy today.

Workflow Strategy 1: Write the Prescription to Maximize Flexibility

Allow generic substitution explicitly: Write the prescription as "fosfomycin tromethamine 3g" and indicate that generic substitution is acceptable. Some pharmacies carry only the generic version and not brand Monurol, while others stock only Monurol. Allowing either gives patients more options.

Send a backup prescription: Consider sending a second prescription for nitrofurantoin 100 mg BID × 5 days or TMP-SMX DS BID × 3 days alongside fosfomycin, with a note for the patient: "Fill ONLY ONE of these. Start with fosfomycin; if unavailable after 2 pharmacy attempts, fill the alternative." This eliminates callbacks and delays.

Use e-prescribing with notes: If using an EHR, add a patient-facing note indicating that if the pharmacy is out of stock, they should call the office for an immediate alternative. Alternatively, pre-populate the alternative and mark it conditional.

Workflow Strategy 2: Recommend medfinder for Providers

medfinder for Providers is a pharmacy-finding tool designed to streamline this exact problem. Rather than having your MA or front desk call pharmacies on the patient's behalf — or having the patient call dozens of numbers while feeling unwell — medfinder contacts pharmacies near the patient and returns results via text.

You can recommend medfinder directly in your after-visit summary: "If your pharmacy is out of stock, visit medfinder.com to find a pharmacy near you that has it."

Workflow Strategy 3: Educate Patients at the Visit

A brief verbal heads-up at the end of the appointment significantly reduces callbacks:

"Fosfomycin is not always stocked at every pharmacy — if your first pharmacy is out, try one or two others before calling us."

"The medication comes as a single packet mixed in water — make sure you ask specifically for fosfomycin tromethamine 3g or Monurol."

"If you can't find it after a couple of tries, call us and we'll send an alternative immediately."

Clinical Decision Guide: Fosfomycin vs. Alternatives

Use this quick reference for selecting alternatives when fosfomycin is unavailable:

Standard uncomplicated UTI (CrCl ≥ 30): Nitrofurantoin 100 mg BID × 5 days (preferred) or TMP-SMX DS BID × 3 days (if local resistance <20%)

Sulfa allergy + reduced CrCl: Consider cephalexin 500 mg BID × 7 days (second-line, higher resistance rates)

Pregnancy: Nitrofurantoin (avoid at 36+ weeks), cephalexin; consult OB for further guidance

Suspected MDR / ESBL UTI: Fosfomycin is often preferred; if unavailable, await culture results before defaulting to carbapenems when possible

Stewardship Note: Avoid Reflexively Prescribing Fluoroquinolones

When fosfomycin is unavailable, fluoroquinolones (ciprofloxacin, levofloxacin) should not be the default substitute for uncomplicated UTIs. IDSA guidelines and FDA safety advisories note that fluoroquinolones carry risks of tendon damage, peripheral neuropathy, and C. diff, and their broad use for uncomplicated cystitis is discouraged. Use nitrofurantoin or TMP-SMX as the first substitute, with fluoroquinolones reserved for complicated infections or when culture results indicate no other option.

For the current supply status and additional clinical context, see: Fosfomycin Shortage: What Providers and Prescribers Need to Know in 2026